Apollo Hospitals Sees Significant Open Interest Surge Amid Rising Market Momentum

Open Interest and Volume Dynamics

The latest data reveals that Apollo Hospitals’ open interest (OI) in derivatives has risen sharply by 4,304 contracts, representing an 11.64% increase from the previous figure of 36,979 to 41,283. This substantial uptick in OI is accompanied by a trading volume of 30,476 contracts, underscoring heightened activity among traders and institutional participants.

In monetary terms, the futures segment alone accounted for a value of approximately ₹62,860.75 lakhs, while the options segment exhibited an enormous notional value of ₹22,386.49 crores. The combined derivatives turnover thus stands at ₹64,356.13 lakhs, reflecting robust liquidity and investor interest in Apollo Hospitals’ contracts.

Price Performance and Market Context

On the price front, Apollo Hospitals has been gaining steadily, with a 1-day return of 1.99%, marginally outperforming the hospital sector’s 1.94% and closely tracking the Sensex’s 1.98% gain. The stock has recorded consecutive gains over the past two sessions, delivering a cumulative return of 5.8% during this period. Intraday, it touched a high of ₹7,598, marking a 2.5% rise from the previous close.

Technical indicators show the stock trading above its 5-day, 50-day, 100-day, and 200-day moving averages, though it remains slightly below the 20-day moving average. This mixed technical picture suggests a consolidation phase with underlying strength, supported by rising investor participation.

Delivery volumes have surged notably, with 3.59 lakh shares delivered on 24 March, a 31.83% increase over the 5-day average delivery volume. This rise in delivery volume signals genuine accumulation rather than speculative trading, reinforcing the positive price momentum.

Market Capitalisation and Analyst Ratings

Apollo Hospitals Enterprise Ltd. is a large-cap stock with a market capitalisation of ₹1,08,414 crores, firmly established within the hospital sector. The company’s Mojo Score currently stands at 52.0, reflecting a Hold rating, a downgrade from a previous Buy rating as of 9 January 2026. This shift indicates a more cautious stance by analysts, possibly due to valuation concerns or sector headwinds, despite the recent positive price action.

Interpreting the Open Interest Surge

The 11.64% increase in open interest suggests that new positions are being established rather than existing ones being squared off. This typically indicates fresh capital inflows and growing conviction among market participants. Given the concurrent rise in price and volume, the directional bias appears to be bullish.

Such a pattern often reflects expectations of further upside in the underlying stock, with traders positioning themselves to benefit from anticipated gains. The fact that the stock is trading above most key moving averages lends technical support to this view.

However, the slight dip below the 20-day moving average signals some short-term resistance, which investors should monitor closely. The delivery volume spike also points to genuine investor interest rather than purely speculative activity, which is a positive sign for sustainable price appreciation.

Sectoral and Broader Market Implications

Apollo Hospitals, as a leading player in the hospital sector, often serves as a bellwether for healthcare industry trends. The stock’s performance and derivatives activity can provide insights into sectoral sentiment. The hospital sector’s 1-day return of 1.94% aligns closely with Apollo’s gains, indicating sector-wide optimism.

Given the large-cap status and significant market capitalisation, movements in Apollo Hospitals can influence broader indices such as the Sensex, which recorded a 1.98% gain on the same day. The stock’s liquidity, with a tradable size of approximately ₹7.7 crores based on 2% of the 5-day average traded value, ensures that institutional investors can enter or exit positions without undue price impact.

Potential Risks and Analyst Caution

Despite the positive momentum, the downgrade from Buy to Hold by MarketsMOJO analysts on 9 January 2026 reflects some caution. The Mojo Grade of Hold at 52.0 suggests that while the stock remains fundamentally sound, valuation levels or near-term uncertainties may temper upside potential.

Investors should consider these factors alongside the technical and derivatives market signals. The hospital sector can be sensitive to regulatory changes, policy shifts, and macroeconomic factors such as inflation and interest rates, which may impact profitability and growth prospects.

Investor Takeaway

For investors and traders, the surge in open interest combined with rising volumes and price gains in Apollo Hospitals Enterprise Ltd. signals a positive market stance. The stock’s ability to sustain above key moving averages and the increase in delivery volumes suggest genuine accumulation and confidence in the company’s prospects.

However, the Hold rating and recent downgrade advise prudence. Investors should weigh the current bullish momentum against valuation considerations and sectoral risks. Monitoring the 20-day moving average and open interest trends in the coming sessions will be crucial to gauge whether the upward trend can be maintained.

Overall, Apollo Hospitals remains a key stock to watch within the hospital sector, with derivatives market activity providing valuable clues to investor sentiment and potential directional bets.

Summary of Key Metrics:

• Open Interest: 41,283 contracts (up 11.64%)
• Volume: 30,476 contracts
• Futures Value: ₹62,860.75 lakhs
• Options Value: ₹22,386.49 crores
• Combined Derivatives Turnover: ₹64,356.13 lakhs
• Underlying Price: ₹7,560
• 1-Day Return: 1.99% (vs Sector 1.94%, Sensex 1.98%)
• Mojo Score: 52.0 (Hold, downgraded from Buy on 09 Jan 2026)
• Market Cap: ₹1,08,414 crores (Large Cap)

Conclusion

Apollo Hospitals Enterprise Ltd.’s recent open interest surge in derivatives, coupled with rising volumes and positive price action, highlights growing investor interest and potential bullish positioning. While technical indicators and delivery volumes support this optimism, the Hold rating and valuation concerns counsel a balanced approach. Investors should continue to monitor market signals and sector developments to make informed decisions in this large-cap hospital stock.

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →